Ociperlimab
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Ociperlimab, covering 2023-07-24 to 2025-09-16. Get the full timeline:
Most recent: Clinical Trial Update: Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer [Phase 2]